Registration is complimentary for credentialed news media.
American Association for Cancer Research Welcomes New Board of Directors, Nominating Committee Members
Elizabeth M. Jaffee, MD, Named American Association for Cancer Research President-Elect 2017-2018
American Association for Cancer Research Announces 2017 Class of Fellows of the AACR Academy
AACR Strongly Opposes the Draconian Cuts to Medical Research Proposed in President Trump’s FY 2018 Budget
AACR Annual Meeting 2017, April 1-5, 2017
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept. 6-9, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
This blog post covers the recent FDA approval of the molecularly targeted therapeutic ribociclib (Kisqali) for use in combination with any aromatase inhibitor for initial treatment of postmenopausal women with a specific subtype of breast cancer.
NBC News.com reports on this study published in the AACR journal Cancer Research.